FTC clears Amgen Horizon buyout: What it means for other pharma deals
Some analysts and M&A experts say the settlement agreement doesn't mean that the FTC will stop baring its teeth at other large buyouts in the industry.
Source: cnbc.com
Page 6 - Evaluate Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Evaluate Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Evaluate Pharma Today - Breaking & Trending Today
3 Reasons to Buy Eli Lilly Stock | The Motley Fool
Shares of the giant drugmaker aren't far off their 52-week high.
Source: fool.com
Evaluate Forecasts Global Pharmaceutical market to be worth $1.6tn in 2028
Mike Gallup, CEO of Norstella, Evaluate’s parent company said: “Key assumptions that have underpinned the pharmaceutical sector for so long – for example, the US market’s supreme profitability and reliance on big M&A to fuel growth – are being tested. “The far-reaching Inflation Reduction Act (IRA), combined with ...
Source: pharmiweb.com
2 Great Stocks Under $100 to Buy and Hold for 10 Years
Neither has performed well over the past year, but investors would do well to focus on the longer term.
Source: fool.com
Merck Q2 Earnings Preview: Analyst Expectations, Jim Cramer's View, And The Spotlight On Keytruda - Merck & Co (NYSE:MRK)
Pharmaceutical company Merck & Company (NYSE: MRK) reports second quarter financial results before market open Tuesday.
Source: benzinga.com